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Morphological Control of Self-Assembled Multivalent (SAMul) 
Heparin Binding in Highly Competitive Media  
Ana C. Rodrigo,a Stephen M. Bromfield,a Erik Laurini,b Paola Posocco,b Sabrina Priclb and David K. 
Smith*,a 
Tuning molecular structures of self-assembling multivalent (SAMul) 
dendritic cationic lipopeptides controls the self-assembled 
morphology.  In buffer, spherical micelles formed by higher 
generation systems bind polyanionic heparin better than worm-like 
micelles formed by lower generation systems.  In human serum, the 
binding of spherical micelles to heparin is adversely affected, while 
worm-like micelles maintain their relative binding ability.   
Multivalency is crucial in achieving high-affinity binding in 
biological systems, amplifying weak binding events in highly 
competitive environments.1  Self-assembly is a strategy by 
ǁŚŝĐŚ  ?ďŽƚƚŽŵ-ƵƉ ? ĨĂďƌŝĐĂƚŝŽŶ ŽĨ ŶĂŶŽscale systems can be 
achieved and has emerged as an effective way of organizing 
multiple ligands to enhance binding  ?  ?ƐĞůĨ-assembled 
ŵƵůƚŝǀĂůĞŶĐǇ ?  ?^DƵů ) ?2 A range of SAMul systems for 
biomedical targets has been developed.3  A few elegant studies 
have begun to focus on morphology,4 but its impact on binding 
remains to be fully elucidated.  Heparin, a polyanionic 
glycosaminoglycan is a target of considerable interest, due to its 
clinical applications.5  There has been general interest in binding 
polyanions using colloidal polycations.6   Self-assembled 
nanoscale systems such as liposomes have been used to bind 
heparin, primarily with the goal of enhancing liposome 
biocompatibility.7  We have developed SAMul micelles with 
heparin binding potential, demonstrated they can have 
pharmaceutically-useful degradation profiles for heparin 
reversal,8 and performed nanoscale structure-activity 
relationship studies  ? for example exploring the impact of ligand 
chirality on binding.9   Self-assembled polymer micelles have 
also been bound to heparin to enhance drug delivery,10 and 
Kostiainen and co-workers used cationic block copolymer 
micelles to bind heparin, modifying the cationic block to 
optimise binding.11  A self-assembled approach to heparin 
binding has recently been explored by de Grado and co-workers 
who reported that self-assembly was enhanced in the presence 
of heparin and at high ionic strength.12 Stupp and co-workers 
used heparin binding to nucleate the growth of cationic peptide 
nanofibres.13  A key advantage of self-assembly is molecular-
scale programmability by simple synthetic modification.  In this 
paper, we report new dendritic lipopeptide SAMul ligands and 
report the impact of structural modification on self-assembled 
morphology, and hence polyanion binding. 
Figure 1.  Structures of self-assembling dendrons G1 and G2 with a schematic of 
their molecular shapes. 
 We designed systems with different hydrophilic-lipophilic 
balances (HLBs)14 using a dendritic hydrophilic ligand  ? 
amphiphilic dendrons are known to assemble well.15  Dendritic 
cationic L-lysine ligands were synthesised and connected to twin 
aliphatic tails through ester bonds via an L-aspartic acid linker 
(Fig. 1). Synthesis of both L and D enantiomers was achieved 
using simple peptide chemistry and protecting group 
methodologies (see ESI).  First generation G1 was designed to 
be  ?ƌŽĚ-ůŝŬĞ ? ?ǁŚŝůĞƐĞĐŽŶĚŐĞŶĞƌĂƚŝon G2 has a more  ?ĐŽŶĞ-ůŝŬĞ ?
structure.  Multiscale modelling (see ESI for details) confirmed 
the molecular shapes and predicted G1 would assemble into 
worm-like cylindrical micelles, while G2 would form spherical 
micelles (Fig. 2).  We initially anticipated worm-like micelles may 
be better shape-matched to heparin, and bind it more strongly.   
 We determined critical micelle concentrations (CMCNR, 
Table 1) using a Nile Red assay.16  Dendrons G1 and G2 had very 
different CMC values of 67 and 9 PM respectively, suggesting 
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thĞ  ?ĐŽŶĞ-ůŝŬĞ ?G2 dendron is more effective in terms of self-
assembly thermodynamics.  Isothermal titration calorimetry 
(ITC) demicellization experiments confirmed the CMCs (CMCITC, 
Table 1).  Further analysis of ITC data indicated that G2 assembly 
is preferred on entropic grounds  ? with spherical micelles, a 
larger number of smaller nanoscale objects are formed (see 
ESI).  Dynamic light scattering (DLS, Table 1) supported the view 
that G1 formed larger assembled structures  ? in agreement 
with modelling.  Given they are not spherical, the data cannot 
be fitted in a meaningful way, but indicated an equivalent 
average spherical diameter of ca. 125 nm. In contrast, G2 gave 
well-defined assemblies with a diameter of 6.7 nm, consistent 
with the view from modelling that G2 forms small spherical 
micelles.  ]-potential measurements indicated both systems 
formed cationic assemblies. Worm-like G1 assemblies appeared 
more charge dense than G2 spherical assemblies, suggesting a 
more densely packed, less open surface. 
Figure 2.  Worm-like (left) and spherical (right) micelles predicted from simulation 
of G1 and G2, respectively, in solution. The hydrophobic core is highlighted as a 
grey-shaded surface (and grey sticks), while the hydrophilic shell is depicted as 
forest green and blue sticks for G1 and G2, respectively. 
Table 1. Critical Micelle Concentrations (CMCs) for G1 and G2 determined by Nile Red 
assay (PBS, 10 mM pH 7.4, 138 mM NaCl) and ITC experiments (Tris-HCl, 10 mM, pH 7.4, 
NaCl 150 mM) (CMCNR and CMCITC respectively), and ]sizing data from DLS volume 
contribution (Tris-HCl, 10 mM, pH 7.4, NaCl 150 mM). 
 G1 G2 
CMCNR / PM 67 ± 10 9 ± 1 
CMCITC / PM 58 13 
Diameter / nm 125 ± 10a 6.7 ± 0.2 
]-Potential / mV +73.2 ± 3.3a +29.6 ± 2.3 
a: The objects are non-spherical and data therefore only represent the sphere 
which would have the same average translational diffusion coefficient as the 
worm-like micelles.  
 We then determined the relative heparin binding affinities 
of G1 and G2 using our Mallard Blue (MalB) displacement 
assay.17  This gives CE50 and EC50 values corresponding to the 
charge excess and concentration required to displace 50% of 
MalB dye from its complex with heparin.17 It was evident (Table 
2) that in buffer (10 mM Tris-HCl, 150 mM NaCl, pH 7.4), G2-L, 
which assembles into spherical micelles, was a much more 
effective heparin binder than G1-L, with worm-like micellar 
morphology.  The same was observed for enantiomeric G2-D 
and G1-D.  This was initially counter-intuitive, as we had 
anticipated that worm-like G1 micelles may form more contacts 
with heparin  ? furthermore, they had higher apparent charge 
densities (Table 1) which should enhance binding.6  We 
reasoned the higher CMC of G1 may limit effective binding at 
lower concentrations, while the lower CMC of G2 allows SAMul 
binding to be optimized.  Indeed, the EC50 values are in good 
agreement with CMC values, suggesting self-assembly is a pre-
requisite for effective heparin binding. Enantiomeric G1-D and 
G2-D were similar to G1-L and G2-L respectively, suggesting 
limited chiral discrimination at this nanoscale binding interface 
 ? in contrast to some of our previous studies.9 
Table 2.  Heparin Binding Parameters for G1 and G2 determined by MalB displacement 
assay: CE50 (cation:anion charge excess  at which 50% of MalB is displaced from its 
complex) and EC50 (effective concentration at which 50% of MalB is displaced).  Binding 
carried out in Tris-HCl buffer (10 mM, pH 7.4, 150 mM NaCl) or 100% human serum (Tris-
HCl 10 mM, pH 7.4). 
  Buffer Serum 
G1-L CE50 1.11 ± 0.21 1.15  ± 0.05 
EC50 / PM 59.9 ± 11.3 61.9 ± 2.6 
G1-D CE50 0.97 ± 0.01 0.93 ± 0.16 
EC50 / PM 52.2 ± 0.3 50.2 ± 8.6 
G2-L CE50 0.51 ± 0.05 0.85 ± 0.02 
EC50 / PM 13.8 ± 0.7 23.1 ± 0.5 
G2-D CE50 0.63 ± 0.02 1.24 ± 0.03 
EC50 / PM 16.9 ± 0.5 33.5 ± 0.8 
 
 Given our surprise at the enhanced performance of 
spherical G2 over worm-like G1, we performed ITC to validate 
the results.  SAMul nanostructures formed by G1-L and G2-L 
were titrated into heparin, such that they always remained 
above their CMC values, to limit any effects of micelle formation 
on the heparin binding event.  The ITC profiles for both systems 
had similar shapes implying similar mechanisms of 
complexation (Fig. 3), with each aliquot addition completely 
interacting with heparin. We therefore propose that complexes 
form without significant change in morphology.  In both cases, 
titration endpoints were observed at a molar ratio of ca. 1.   
 Binding between heparin and SAMul G1-L and G2-L occurred 
with positive enthalpy values 'Hobs of 8.03s0.17 kJmol-1 and 
6.82s0.14 kJmol-1, respectively (Fig. 3), compensated by 
higher positive entropy terms 'Sobs (+118.8s0.6 Jmol-1K-1 for 
G1-L and +130.2s0.6 Jmol-1K-1 for G2-L, Fig. 3), which can be 
ascribed to the release into bulk solvent of water and 
counterions from the contact surfaces between the polyanion 
and the cationic SAMul entities.  The favourable entropy is 
significantly greater for G2-L than G1-L  ? the spherical micelles 
based on higher generation dendritic ligands have much larger 
surface areas to desolvate.  Endothermic, entropically-driven 
binding has been reported previously for electrostatic binding 
at charged nanoscale interfaces.18 and we propose that it 
provides the driving force here.  The free energy of binding 
'Gobs is favourable ('Gobs is -27.36s0.61 kJmol-1 and -31.98s
0.56 kJmol-1 for G1-L and G2-L, respectively, Fig. 3).  Most 
importantly, binding is stronger for G2-L than G1-L (''Gobs = 
4.62 kJmol-1).  ITC therefore validates the MalB assay and 
supports the view that G2 spherical micelles are indeed more 
effective heparin binders. Similar morphological effects, i.e., 
better binding for spherical micelles than worm-like micelles, 
were reported for mannopyranoside binding to Concanavalin 
A,4a and RGD peptides binding to integrins,4c but in those cases, 
the reasons were not determined.  ITC suggests that, at least in 
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this case, better self-assembly and greater surface desolvation 
for spherical micelles underpin the enhanced binding effect.  
Figure 3. Titration of heparin with (A) G1-L and (B) G2-L SAMul micelles. Upper 
panels: raw titration data. Lower panels: ITC isotherms for G1-L and G2-L binding 
heparin. Inserts: thermodynamic parameters (binding enthalpy 废Hobs, binding 
entropy  ?T废Sobs, and binding free energy 'Gobs) for G1-L (A) and G2-L (B) micelles. 
See ESI for details. 
We were concerned that heparin binding may disrupt SAMul 
morphologies,4b and thus performed transmission electron 
microscopy (TEM) imaging in the absence and presence of 
heparin.  For G1-L bound to heparin, we pleasingly observed the 
presence of worm-like micelles, which aggregated into larger 
hierarchical structures (see ESI).  For G2-L bound to heparin, the 
spherical micelles of G2-L remained intact, and were also further 
aggregated into a hierarchical nanoscale array (see ESI).  This 
hierarchical assembly mechanism has been discussed in detail 
elsewhere for electrostatically-bound micelle-polyelectrolyte 
complexes.19  TEM therefore supports the morphologies 
predicted by modelling and suggests they are not significantly 
disturbed by electrostatic binding to heparin. 
The relative ability of these compounds to bind heparin in 
much more highly competitive, and biomedically realistic 
conditions of 100% human serum was also monitored using our 
MalB assay (Table 2, Fig. 4).  The spherical G2 micelles were 
adversely affected by serum, with a significant rise in CE50 and 
EC50 values (Fig. 4, bottom), but the G1 worm-like micelles were 
not (Fig. 4, top).  We suggest that G1 has greater relative 
lipophilicity driving self-assembly, and its nanostructures are 
less easily disrupted by the presence of serum albumins, which 
bind lipophilic groups.20 As such, the worm-like micelles better 
maintain heparin binding in 100% human serum.  It is known 
from other biomedical applications of surfactants for drug/gene 
delivery that spherical micelles have lower stability in 
challenging environments than other morphologies or 
stabilized micelles which can resist competition.21  The results 
presented here demonstrate that morphology can also control 
multivalent binding strength at self-assembled nanosurfaces.  
The D-enantiomers were affected in the same way as their L-
analogues  (Table 2).  Once again, differences between the 
enantiomers were limited  ? although there was some evidence 
that G2-L may be a slightly better binder than G2-D under these 
more challenging conditions, which might suggest that there is 
a small degree of chiral recognition at the relatively open 
surfaces of the spherical micelles.  
Figure 4.  Relative performances of compounds G1-L (top) and G2-L (bottom) in 
the MalB displacement assay in the absence (blue) and presence (green) of serum, 
demonstrated the disruption of binding experienced by compound G2-L. 
 The ester linker introduces potential for these structures to 
degrade under physiological conditions through cleavage  ? 
switching off self-assembly and hence SAMul binding.22  It was 
demonstrated by mass spectrometry that all compounds 
degrade under physiological pH conditions via ester hydrolysis 
over a 24 hour time period (see ESI), meaning these compounds 
have pharmaceutically useful degradation profiles for heparin 
reversal  ? any excess highly-active SAMul system will degrade 
to give non-self-assembling, non-active fragments. 
 In summary, spherical G2 micelles are optimized for self-
assembly and heparin binding in buffer as a result of the lower 
CMC and open dendritic surface, with accessible ligands that are 
desolvated on binding heparin, providing an entropic driving 
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force.  However, worm-like G1 micelles better retain their 
heparin binding in serum, while spherical micelles of G2 are 
disrupted.  It is clearly important to carefully consider binding 
environment when applying SAMul nanosystems.  For in vivo 
applications, it is crucial to maximise stability and binding in 
challenging conditions.  The ease with which molecular-scale 
structures can be modified and translated into programmable 
nanoscale morphologies is a significant advantage of the SAMul 
approach over other multivalent binding strategies  ? we 
suggest morphological optimization of SAMul systems will be a 
key strategy for a variety of biological targets 
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